Back during my business journalist days – the 22 years I spent working on news stories all around the world – I used to look at myself as the “agent for the reader.”
And with good reason.
You see, I knew that – as a journalist – I was getting opportunities the typical person never gets. I could go places, get access to important people, and ask questions my readers never could.
So I always kept those folks in mind as I went about my business.
And I brought that “agent for the reader” mindset to my Private Briefing subscribers, as well.
I’m sharing this story for a reason.
I recently had another one of those opportunities I was referring to.
I got the chance to interview the CEO of a “cannabis revolution company.”
But before we get to the interview, here’s a little background on the company…
Legal Weed Investors Need to Get In on This
The company in question is Nemus Bioscience Inc. (OTC: NMUS), a Long Beach, California–based biotech focused on the development of cannabinoid-based therapeutics, including a treatment for glaucoma.
The company has a $35 million market cap, a partnership with the University of Mississippi, and a real drug pipeline. It also announced a new financing deal just last week.
Critical Update: You’re invited to the first-ever national event for cannabis investors. Click here to register for this free online event.
The CEO – the exec that I interviewed – is Dr. Brian Murphy, a former medical-school professor and biotech-sector veteran.
The interview, which I link to below, was incredibly detailed – offering deep insights about Nemus and about the “Legal Cannabis Revolution.”
This is one of the next big opportunities for investors.
Two years ago, the market for legally sanctioned marijuana was worth about $14.3 billion. Research says the market will hit $20 billion this year and could zoom to $63.5 billion by 2024.
Truthfully, I think those numbers are ridiculously conservative: I’ve read detailed reports stating that when you look at the entirety of this sector – food, drink, medications, supplements, personal care, recreation… everything – we’ll be looking at a massive, cannabis-based “wellness” market by the middle of the next decade.
The bottom line: As your “agent,” I want to help you get a solid handle on what could be one of the biggest new wealth plays we’ll be watching.
And I believe this interview will help: The CEO was really forthcoming about this market and was a terrific interviewee.
You can access it by clicking on the image below.
Speaker Boehner Reveals Three Events That Will Transform the Cannabis Industry Forever
He’s connected on Capitol Hill. He golfs with the president. And he knows all the major players in the cannabis industry.
Make no mistake, Speaker Boehner has the inside track on the future of this green gold rush.
And on Tuesday, Oct. 23, he’s agreed to take you deep inside our nation’s most controversial – most misunderstood – and what’s quickly becoming our most lucrative industry.
Just click here to register for this free, once-in-a-lifetime event.
About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.To get full access to all Money Morning content, click here.
Disclaimer: © 2018 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.
